These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


112 related items for PubMed ID: 17867488

  • 1. [The antibacterial activity of fluoroquinolones against gram-negative bacteria isolated from Gifu Prefecture (2005)].
    Tanaka T, Mitsuyama J, Yamaoka K, Asano Y, Hashido H, Matsukawa Y, Matsubara S, Sawamura H, Suematsu H, Terachi M, Miyabe T, Mikamo H, Watanabe K, Working Group of Tokai Anti-biogram Study Group.
    Jpn J Antibiot; 2007 Jun; 60(3):141-52. PubMed ID: 17867488
    [Abstract] [Full Text] [Related]

  • 2. [Post-marketing surveillance of antibacterial activities of cefozopran against various clinical isolates--II. Gram-negative bacteria].
    Igari J, Oguri T, Hiramatsu N, Akiyama K, Koyama T.
    Jpn J Antibiot; 2002 Feb; 55(1):22-60. PubMed ID: 11977920
    [Abstract] [Full Text] [Related]

  • 3. [Post-marketing surveillance of antibacterial activities of cefozopran against various clinical isolates--II. Gram-negative bacteria].
    Igari J, Oguri T, Hiramatsu N, Akiyama K, Koyama T.
    Jpn J Antibiot; 2003 Oct; 56(5):458-96. PubMed ID: 14692381
    [Abstract] [Full Text] [Related]

  • 4. [Nationwide susceptibility surveillance of ciprofloxacin and various parenteral antimicrobials against bacteria isolated from patients with severe infections--third ciproxan injection special survey (2005)].
    Yamaguchi K, Ishii Y, Yamanaka K, Watanabe N, Uehara N, Kaku M, Okabe T, Ito K, Nagasawa M, Baba H, Ichiyama S, Kurokawa Y, Negayama K, Hirakata Y.
    Jpn J Antibiot; 2008 Aug; 61(4):241-68. PubMed ID: 19024645
    [Abstract] [Full Text] [Related]

  • 5. Japanese nationwide surveillance in 2011 of antibacterial susceptibility patterns of clinical isolates from complicated urinary tract infection cases.
    Ishikawa K, Hamasuna R, Uehara S, Yasuda M, Yamamoto S, Hayami H, Takahashi S, Matsumoto T, Minamitani S, Kadota J, Iwata S, Kaku M, Watanabe A, Sunakawa K, Sato J, Hanaki H, Tsukamoto T, Kiyota H, Egawa S, Deguchi T, Matsumoto M, Tanaka K, Arakawa S, Fujisawa M, Kumon H, Kobayashi K, Matsubara A, Wakeda H, Amemoto Y, Onodera S, Goto H, Komeda H, Yamashita M, Takenaka T, Fujimoto Y, Tsugawa M, Takahashi Y, Maeda H, Onishi H, Ishitoya S, Nishimura K, Mitsumori K, Ito T, Togo Y, Nakamura I, Ito N, Kanamaru S, Hirose T, Muranaka T, Yamada D, Ishihara S, Oka H, Inatomi H, Matsui T, Kobuke M, Kunishima Y, Kimura T, Ichikawa T, Kagara I, Matsukawa M, Takahashi K, Mita K, Kato M, Okumura K, Kawanishi H, Hashimura T, Aoyama T, Shigeta M, Koda S, Taguchi K, Matsuda Y.
    J Infect Chemother; 2015 Sep; 21(9):623-33. PubMed ID: 26166322
    [Abstract] [Full Text] [Related]

  • 6. [Antibacterial activities of monobactams against fresh clinical isolates].
    Deguchi K, Yokota N, Koguchi M, Nakane Y, Fukayama S, Nishimura Y, Oda S, Tanaka S, Kato M, Sato K.
    Jpn J Antibiot; 1988 Nov; 41(11):1600-22. PubMed ID: 3210297
    [Abstract] [Full Text] [Related]

  • 7. [Nationwide surveillance of parenteral antibiotics containing meropenem activities against clinically isolated strains in 2006].
    Yamaguchi K, Ishii Y, Iwata M, Watanabe N, Uehara N, Yasujima M, Kasai T, Suwabe A, Yamahata K, Kaku M, Kanemitsu K, Imafuku Y, Nishiyama K, Murakami M, Yomoda S, Taniguchi N, Yamada T, Nomura F, Watanabe M, Kanno H, Aihara M, Maesaki S, Hashikita G, Kondo S, Misawa S, Horiuchi H, Tazawa Y, Nakashima H, Takemura H, Okada M, Yamazaki F, Horii T, Maekawa M, Baba H, Ishigo S, Fujita N, Komori T, Ichiyama S, Iinuma Y, Maeda S, Yamanaka K, Murata Y, Matsuo S, Kohno H, Kinoshita S, Fujita J, Negayama K, Murase M, Miyamoto H, Kusano N, Mihara E, Itaha H, Ono J, Yoshimura H, Yanagihara K, Matsuda J, Saikawa T, Hiramatsu K.
    Jpn J Antibiot; 2007 Dec; 60(6):344-77. PubMed ID: 18447206
    [Abstract] [Full Text] [Related]

  • 8. [Susceptibility of 570 Pseudomonas aeruginosa strains to 11 antimicrobial agents and the mechanism of its resistance to fluoroquinolones].
    Lei YC, Wang HB, Sun ZY, Shen ZY.
    Zhonghua Yi Xue Za Zhi; 2003 Mar 10; 83(5):403-7. PubMed ID: 12820918
    [Abstract] [Full Text] [Related]

  • 9. [Yearly changes in antibacterial activities of cefozopran against various clinical isolates between 1996 and 2000--II. Gram-negative bacteria].
    Suzuki Y, Nishinari C, Endo H, Tamura C, Jinbo K, Hiramatsu N, Akiyama K, Koyama T.
    Jpn J Antibiot; 2002 Apr 10; 55(2):154-80. PubMed ID: 12071094
    [Abstract] [Full Text] [Related]

  • 10. Evaluation of the in vitro activity of fosfomycin tromethamine against Gram-negative bacterial strains recovered from community- and hospital-acquired urinary tract infections in Turkey.
    Demir T, Buyukguclu T.
    Int J Infect Dis; 2013 Nov 10; 17(11):e966-70. PubMed ID: 23742831
    [Abstract] [Full Text] [Related]

  • 11. Analysis of Salmonella spp. with resistance to extended-spectrum cephalosporins and fluoroquinolones isolated in North America and Latin America: report from the SENTRY Antimicrobial Surveillance Program (1997-2004).
    Biedenbach DJ, Toleman M, Walsh TR, Jones RN.
    Diagn Microbiol Infect Dis; 2006 Jan 10; 54(1):13-21. PubMed ID: 16290025
    [Abstract] [Full Text] [Related]

  • 12. [Nationwide sensitivity surveillance of ciprofloxacin and various parenteral antibiotics against bacteria isolated from patients with severe infections--the first Ciproxan IV special investigation in 2001].
    Yamaguchi K, Ishii Y, Iinuma Y, Yamanaka K, Ichiyama S, Watanabe N, Uehara N, Kaku M, Kurokawa Y, Hayashi M, Hirakata Y.
    Jpn J Antibiot; 2003 Dec 10; 56(6):546-73. PubMed ID: 15007872
    [Abstract] [Full Text] [Related]

  • 13. [Yearly changes in antibacterial activities of cefozopran against various clinical isolates between 1996 and 2001--II. Gram-negative bacteria].
    Suzuki Y, Nishinari C, Endo H, Hiramatsu N, Akiyama K, Koyama T.
    Jpn J Antibiot; 2003 Aug 10; 56(4):309-35. PubMed ID: 14567255
    [Abstract] [Full Text] [Related]

  • 14. [Mutations in gyrA and gyrB genes among strains of Gram-negative bacilli isolated from Chilean hospitals and their relation with resistance to fluoroquinolones].
    De la Fuente C M, Dauros S P, Bello T H, Domínguez Y M, Mella M S, Sepúlveda A M, Zemelman Z R, González R G.
    Rev Med Chil; 2007 Sep 10; 135(9):1103-10. PubMed ID: 18064363
    [Abstract] [Full Text] [Related]

  • 15. In vitro activity of clinafloxacin against fluoroquinolone resistant Spanish clinical isolates.
    López-Brea M, Prieto N, Domingo D, de las Cuevas C, Sánchez I, Alarcón T.
    Int J Antimicrob Agents; 1999 Jun 10; 12(1):33-9. PubMed ID: 10389645
    [Abstract] [Full Text] [Related]

  • 16. [Antibacterial activities of isepamicin against fresh clinical isolates of gram-negative bacilli].
    Deguchi K, Yokota N, Koguchi M, Suzuki Y, Fukayama S, Ishihara R, Oda S, Tanaka S, Nakane Y, Fukamoto T.
    Jpn J Antibiot; 1994 Aug 10; 47(8):1053-64. PubMed ID: 7933534
    [Abstract] [Full Text] [Related]

  • 17. In vitro antimicrobial activity of fluoroquinolones against clinical isolates obtained in 1989 and 1990.
    Chen YC, Chang SC, Hsu LY, Hsieh WC, Luh KT.
    J Formos Med Assoc; 1993 Dec 10; 92(12):1040-8. PubMed ID: 7911351
    [Abstract] [Full Text] [Related]

  • 18. [Surveillance of antimicrobial resistance among nosocomial gram-negative pathogens from 15 teaching hospitals in China in 2005].
    Yang QW, Xu YC, Chen MJ, Hu YJ, Ni YX, Sun JY, Yu YS, Kong HS, He L, Wu WY, Ye HF, Yang YM, Zhu LN, Guo SH, Ji P, Zhu ZH, Ren JK, Zhang LX, Sun ZY, Zhu XH, Tong MQ, Zhao WS, Mei YN, Liu Y, Zhang ZJ, Duan Q, Li D, Liu PP, Wang J, Han LX, Wang H, Xie XL.
    Zhonghua Yi Xue Za Zhi; 2007 Oct 23; 87(39):2753-8. PubMed ID: 18167265
    [Abstract] [Full Text] [Related]

  • 19. [Antibacterial activity of ciprofloxacin against fresh clinical isolates from superficial suppurative foci].
    Deguchi K, Yokota N, Koguchi M, Nakane Y, Suzuki Y, Fukayama S, Ishihara R, Oda S, Tanaka S, Sato K.
    Jpn J Antibiot; 1991 Feb 23; 44(2):117-29. PubMed ID: 2041153
    [Abstract] [Full Text] [Related]

  • 20. [Continuous surveillance of antimicrobial resistance among nosocomial gram-negative bacilli from intensive care units in China].
    Chen MJ, Wang H, China Nosocomial Pathogens Resistance Surveillance Study Group.
    Zhonghua Yi Xue Za Zhi; 2003 Mar 10; 83(5):375-81. PubMed ID: 12820912
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.